日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication

从金融经济学角度评估医疗保健投资价值，降低系统级风险：以疾病消除和根除为例

期刊:Applied Health Economics and Health Policy
影响因子:3.3
doi:10.1007/s40258-026-01037-3
Rao, Megha; Freeman, Mark; Thijssen, Jacco; Bland, Simon; Sculpher, Mark; Claxton, Karl; Revill, Paul
发表日期：2026
文献求助 收藏

Revised methods guide for economic evaluation studies of health technologies in Portugal

葡萄牙卫生技术经济评价研究方法指南修订版

期刊:International Journal of Technology Assessment in Health Care
影响因子:3.1
doi:10.1017/S0266462325103413
Soares, Marta O; Perelman, Julian; Mateus, Ceu; Duarte, Ana; Faria, Rita; Ferreira, Lara N; Saramago, Pedro; Veiga Benesch, Paula; Furtado, Claudia; Teixeira, Maria do Céu; Caldeira, Sónia; Sculpher, Mark
发表日期：2026
文献求助 收藏

FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making

FRAME：用于降低疗效/有效性证据不确定性的真实世界证据评估框架——监管和卫生技术评估决策的评估

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3713
Candore, Gianmario; Martin, Claire; Mills, Mack J; Suter, Annabel; Lloyd, Anna; Chavez-Montoya, Danitza; Civitelli, Diego; Wolf, Birgit; Bolot, Paul; Wasem, Juergen; Soriano Gabarró, Montse; Kanavos, Panos G; Sculpher, Mark
发表日期：2025
文献求助 收藏

Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence

更正：在治疗方法、价格和证据不断变化的背景下，利用成本效益分析支持新药定价和报销决策的框架

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-025-01513-z
Woods, Beth; Palacios, Alfredo; Sculpher, Mark
发表日期：2025
文献求助 收藏

‘It's Hard to Look Past the Accessibility’: Service Provider Perspectives on Implementing Telehealth for Alcohol and Other Drug Counselling as a Health Service Innovation

“其可及性不容忽视”：服务提供者对将远程医疗应用于酒精和其他药物咨询作为一项健康服务创新的看法

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-024-01450-3
Woods, Beth; Palacios, Alfredo; Sculpher, Mark; Bartram, Ashlea; Ahad, Md Abdul; Long, April; Lubman, Dan I; Morrison, Ele; Rundle, Jill; Lee, Nicole; Wilson, Scott; Bowden, Jacqueline
发表日期：2025
文献求助 收藏

Development of the natural history component of an early economic model for primary sclerosing cholangitis

早期原发性硬化性胆管炎经济模型自然史部分的构建

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-025-03658-8
Bowlus, Christopher; Levy, Cynthia; Kowdley, Kris V; Kachru, Nandita; Jeyakumar, Sushanth; Rodriguez-Guadarrama, Yael; Smith, Nathaniel; Briggs, Andrew; Sculpher, Mark; Ollendorf, Daniel
发表日期：2025
文献求助 收藏

Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model

在英国将Nuvaxovid引入COVID-19疫苗接种的成本效益：动态传播模型

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13020187
Pritchard, Clive; Kutikova, Lucie; Pitman, Richard; Lai, Kira Zhi Hua; Beyhaghi, Hadi; Gibbons, IIana; Erbe, Amanda; Živković-Gojović, Marija; Cosgrove, Catherine; Sculpher, Mark; Salisbury, David
发表日期：2025
文献求助 收藏

Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

评估新型抗菌药物的价值：对头孢地洛和头孢他啶-阿维巴坦的评估，以指导英格兰国民医疗服务体系（NHS）的脱钩支付

期刊:Applied Health Economics and Health Policy
影响因子:3.3
doi:10.1007/s40258-024-00924-x
Woods, Beth; Kearns, Ben; Schmitt, Laetitia; Jankovic, Dina; Rothery, Claire; Harnan, Sue; Hamilton, Jean; Scope, Alison; Ren, Shijie; Bojke, Laura; Wilcox, Mark; Hope, William; Leonard, Colm; Howard, Philip; Jenkins, David; Ashworth, Alan; Bentley, Andrew; Sculpher, Mark
发表日期：2025
文献求助 收藏

Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

更正：评估新型抗菌药物的价值：对头孢地洛和头孢他啶-阿维巴坦的评估，以指导英格兰国民医疗服务体系（NHS）的脱钩支付

期刊:Applied Health Economics and Health Policy
影响因子:3.3
doi:10.1007/s40258-025-00979-4
Woods, Beth; Kearns, Ben; Schmitt, Laetitia; Jankovic, Dina; Rothery, Claire; Harnan, Sue; Hamilton, Jean; Scope, Alison; Ren, Shijie; Bojke, Laura; Wilcox, Mark; Hope, William; Leonard, Colm; Howard, Philip; Jenkins, David; Ashworth, Alan; Bentley, Andrew; Sculpher, Mark
发表日期：2025
文献求助 收藏

Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making

指导卫生资源分配：利用人口净健康效益将疾病负担与成本效益相结合，以做出明智的决策

期刊:Applied Health Economics and Health Policy
影响因子:3.3
doi:10.1007/s40258-025-00964-x
Rao, Megha; Walker, Simon; Claxton, Karl; Bland, Simon; Ochalek, Jessica; Phillips, Andrew; Sculpher, Mark; Revill, Paul
发表日期：2025
文献求助 收藏